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Sodium channelResurgent sodium currents likely play a role in modulating neuronal excitability. Here we studied
whether protein kinase C (PKC) activation can increase resurgent currents produced by the human
sodium channel hNav1.7. We found that a PKC agonist signiﬁcantly enhanced hNav1.7-mediated
resurgent currents and this was prevented by PKC antagonists. The enhancing effects were
replicated by two phosphorylation-mimicking mutations and were prevented by a phosphoryla-
tion-deﬁcient mutation at a conserved PKC phosphorylation site (Serine 1479). Our results suggest
that PKC can increase sodium resurgent currents through phosphorylation of a conserved Serine
residue located in the domain III–IV linker of sodium channels.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Resurgent currents are generated by a subset of voltage-gated
sodium channels (VGSC) during repolarization of the action poten-
tial (AP) when sodium channels are normally thought to be inacti-
vated and refractory to activation [16]. They can provide a
depolarizing drive for AP regeneration, and therefore likely con-
tribute to modulating neuronal excitability. Sodium channel muta-
tions associated with multiple diseases including paroxysmal
extreme pain disorder (PEPD), paramyotonia congenita, and long
QT-3 dramatically increase resurgent currents and neuronal excit-
ability when expressed in dorsal root ganglion (DRG) neurons [12].
Recently we found that resurgent currents in DRG neurons were
signiﬁcantly enhanced by a group of inﬂammatory mediators
including PGE2, Bradykinin, ATP, histamine, and serotonin [20].These inﬂammatory mediators are known to increase excitability
of DRG neurons through activation of cell signaling pathways. Pre-
viously it was shown that phosphorylation of some component of
the sodium channel complex substantially modulated resurgent
currents in cerebellar Purkinje neurons [7]. Protein kinase C
(PKC) can be activated by several of the inﬂammatory mediators
listed above [17,27] and therefore we postulated that PKC activa-
tion might modulate resurgent sodium currents.
In the current report, we ﬁrst tested if PKC activation can
increase resurgent currents generated in the human sodium chan-
nel hNav1.7 expressed in human embryonic kidney 293 (HEK293)
cells. We found that the PKC agonist phorbol 12-myristate 13-ace-
tate (PMA) signiﬁcantly enhanced hNav1.7-mediated resurgent
currents and that this effect was prevented by the PKC antagonists
bisindolylmaleimide I (Bis I) or chelerythrine. We further tested if a
conserved PKC phosphorylation site, S1479 is involved in the
enhancing effects of PMA on resurgent currents utilizing site-direc-
ted mutagenesis. We found that the enhancing effects were mim-
icked by two phosphorylation-mimicking mutations and were
prevented by a phosphorylation-deﬁcient mutation. Furthermore,
we found that PMA signiﬁcantly increased resurgent currents gen-
erated by a hNav1.7 mutant that is associated with PEPD. Our
results suggest that PKC can increase sodium resurgent currents
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linker of sodium channels.
2. Materials and methods
2.1. Cell lines
stably transfected cell lines were prepared as described before
[21]. Brieﬂy, mutations of hNav1.7 including S1479D, S1479E,
S1479A, and M1627K were generated using the QuikChange II XL
site-directed mutagenesis kit (Agilent Technologies, Santa Clara,
CA). DNAs of wild-type (WT) and mutations of hNav1.7 were trans-
fected into HEK293 cells using the calcium phosphate technique.
Stable cell lines expressing WT and mutant hNav1.7 were selected
after 3 weeks of incubation with G418. Stocks of stable cell lines
were frozen at 80 C.
2.2. Cell culture
HEK293 cells expressing WT or mutant hNav1.7 were thawed
and grown in petri dishes until they were plated on glass coverslips
coated with poly-D-lysine and laminin. Cells were incubated in
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% fetal
bovine serum at 37 C in a humidiﬁed 95% air and 5% CO2
incubator.
2.3. Voltage clamp
Whole-cell patch clamp recordings were conducted in voltage-
clamp mode at room temperature (about 22 C) using a HEKA EPC-
10 ampliﬁer. Data were acquired on a Windows based Pentium IV
computer using the Pulse program (version 8.80; HEKA Elektronik).
Fire polished electrodes (0.8–1.2 MX) were fabricated from 1.7-
mm capillary glass using a Sutter P-97 puller (Novato), and the tips
were coated with sticky wax (KerrLab) to minimize capacitive arti-
facts and enable increased series resistance compensation. The
standard electrode solution consisted of 140 mM CsF, 10 mM NaCl,
1.1 mM EGTA, and 10 mM HEPES, pH 7.3. The standard extracellu-
lar bathing solution contained 140 mM NaCl, 3 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 7.3.
Cells on glass coverslips were transferred to a recording cham-
ber containing 250 ll bathing solution. Series resistance errors
were compensated by 80% or more. Leak currents were linearly
canceled by digital P/–5 subtraction. Cells were held at a mem-
brane potential of 100 mV. Membrane currents were sampled
at 20 kHz, ﬁltered online at 5 kHz, and further ﬁltered at 1 kHz dig-
itally in Pulseﬁt. Whole-cell current recordings were started 3 min
after the whole-cell conﬁguration had been established to allow
adequate time for the electrode solution and cytoplasmic milieu
to equilibrate. Resurgent currents were assayed with a 2-step pro-
tocol that initially depolarized the membrane to +30 mV for 20 ms
before testing for inward resurgent sodium currents by hyperpo-
larizing the membrane potential in 5-mV increments from
5 mV to 85 mV, for 50 ms, before stepping to 80 mV. Each volt-
age step was repeated three times and averaged to accurately
record resurgent currents at each voltage. 200 lM b4 peptide (a
peptide mimicking the C-terminal segment of the sodium channel
b4 subunit, KKLITFILKKTREK-OH) was included in the pipette solu-
tion. The peak transient current–voltage (IV) relationship was
tested using a series of depolarizing voltage steps in 5-mV incre-
ments ranging from 100 to +55 mV. Steady-state inactivation
was tested by a test pulse to 0 mV from a series of 500 ms pre-
holding pulses in 5-mV increments ranging from 130 to 5 mV.
PMA or control DMSO (0.1% v/v) was pretreated for 5 min in the
recording chamber before a patch trial started. Bis I andchelerythrine were pretreated for 15 min in culture and kept in
the recording chamber. All three chemicals were dissolved in
DMSO at 1 mM and were used at a ﬁnal concentration of 1 lM.
2.4. Data analysis
Experimental data were analyzed using Pulseﬁt (version 8.80;
HEKA Elektronik), Origin (version 8.0; OriginLab Corp.), and Micro-
soft Excel software programs. Averaged data were presented as
Mean ± standard error. One way ANOVA with post hoc Tukey test,
and Student t test were used to test the signiﬁcance of statistical
data. The signiﬁcance levels were set at P < 0.05 and P < 0.01.
Resurgent currents were ﬁrst identiﬁed by their kinetics and
gating properties. Compared to fast tail currents which have a lin-
ear IV relationship, resurgent currents develop and decay much
more slowly, and have a ‘‘V’’ shaped IV curve that peaks around
35 mV. Currents showing both criteria were classiﬁed as resur-
gent currents. Currents that did not display both properties were
excluded from analysis. To compare the resurgent currents among
different mutant or treatment groups, ratio resurgent currents
were calculated by normalizing peak resurgent currents to the
peak transient current triggered by a test pulse to 0 mV from a
500 ms holding pulse of 110 mV.
Voltage-gating properties including steady-state activation and
inactivation, and kinetic properties including time-dependent acti-
vation and inactivation were analyzed in Pulseﬁt. Half activation or
inactivation voltage (V0.5), and time constants for activation (sm)
and inaction (sh) were obtained.
3. Results
As shown in Fig. 1, resurgent currents from hNav1.7 expressed
in HEK 293 cells were recorded using the resurgent current proto-
col which ﬁrst inactivated peak transient sodium current by a volt-
age step to +30 mV for 20 ms, and then repolarized cells to a series
of voltage stimuli to test for the re-opening of sodium channels. To
test whether PKC activation can modulate resurgent currents gen-
erated by hNav1.7, we used a PKC agonist PMA and two PKC antag-
onists Bis I and chelerythrine [11,24]. We found that 1 lM PMA
signiﬁcantly increased peak resurgent current amplitude (Fig. 1A,
B, E) without changing the transient current density (measured
with the steady-state inactivation protocol by the 110 to 0 mV
voltage step; 289 ± 39 vs. 273 ± 59 pA/pF, Control vs. PMA). PMA
treatment augmentation of hNav1.7 resurgent current amplitude
was prevented by pretreatment with the PKC antagonists Bis I or
chelerythrine at the concentration of 1 lM (Fig. 1) [23,10]. In addi-
tion, 1 lM PMA also signiﬁcantly shifted the peak voltage, the volt-
age where peak resurgent current was measured (from 39 mV for
control to 33 mV for PMA treated; Suppl. Fig. 1). However, only
Bis I but not chelerythrine prevented this shift (Suppl. Fig. 1). Over-
all the results showed that PKC activation increased the amplitude
of resurgent currents mediated by hNav1.7.
It has been reported that there are three conserved PKC phos-
phorylation sites located in intracellular loops of voltage-gated
sodium channels [28,3]. Two sites are located at the domain I–II
linker along with several PKA sites [3]. The third site is located at
the domain III–IV linker and is close to the IFM inactivation gate
[28]. Because the proposed mechanism for resurgent current acti-
vation is open-channel block induced by the intracellular C-termi-
nal loop of the sodium channel b4 subunit [8], and mutations or
toxins that interfere with sodium channel fast inactivation can
increase resurgent currents [13,14], we suspected that the con-
served phosphorylation site in the domain III–IV linker might be
involved in the effects of PMA on hNav1.7-produced resurgent
currents. To examine this possibility, we mutated this
Fig. 1. Increase of hNav1.7 resurgent currents by PKC activation. Representative resurgent currents were recorded from HEK 293 cells expressing hNav1.7 in the presence of
200 lM b4 peptide in the patch pipettes. The currents were recorded using the voltage protocol shown in (F). Note that currents are scaled to reﬂect the ratio resurgent
currents. The ratio resurgent currents were calculated by normalizing peak resurgent currents to peak transient currents recorded in the same cells. (A and B) PMA
signiﬁcantly increased resurgent currents compared to control. (C and D) PKC antagonists bisindolylmaleimide i (Bis I) or chelerythrine (Che) prevented the increasing effects
of PMA. (E) Summary of ratio resurgent current. The data were presented as Means ± Standard Errors. ⁄P < 0.05, PMA vs. Control (One way ANOVA, Tukey test).
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(S1479D and S1479E) to mimic the phosphorylated state, and to
alanine (S1479A) to prevent phosphorylation. We then constructed
stably transfected HEK 293 cell lines for WT and mutant hNav1.7
and compared their ability to generate resurgent currents. We
found that one phosphorylation-mimicking mutant S1479D dra-
matically increased hNav1.7-generated resurgent currents
(Fig. 2A, B, F). The other phosphorylation-mimicking mutant
S1479E also showed a trend toward increased resurgent current
compared to WT channel (P < 0.1, Tukey test, one way ANOVA)
(Fig. 2A, C, F). The phosphorylation-deﬁcient mutant S1479A did
not signiﬁcantly affect resurgent currents (Fig. 2D), but prevented
the effects of PMA on resurgent currents (Figs. 1 and 2D–F). There
were no signiﬁcant differences in the peak voltage of resurgent
currents between WT and mutants (Supplemental Fig. 1). The
above results suggested that phosphorylation of S1479 in hNav1.7
by PKC can increase resurgent currents.
Our lab previously reported that Nav1.7 mutations associated
with PEPD enhanced resurgent currents in HEK 293 cells [22].
We tested whether PKC activation can further enhance resurgent
currents generated by a PEPD mutant, M1627K. We found that
the PKC agonist PMA signiﬁcantly enhanced resurgent currents
produced by M1627K mutant Nav1.7 channels (Fig. 3). The results
suggest that PKC and M1627K might enhance hNav1.7-produced
resurgent currents through mechanisms that are at least partially
additive.
It has been shown that PKC activation can modulate classic cur-
rent properties of sodium channels [25,5]. To test how the classic
transient hNav1.7 current properties may be modulated by PKC
phosphorylation, we examined the effects of PKC agonist and
antagonists, and S1479 mutations on current properties in the
absence of intracellular b4 peptide (Table 1 and Supplemental
Fig. 2). We found that PKC agonist PMA and S1479 phosphoryla-
tion-mimicking mutants caused similar changes in transient cur-
rent properties of hNav1.7 (Table 1 and Supplemental Fig. 2).
Both PMA and S1479E signiﬁcantly shifted the half activationpotential to more depolarized potentials; both PMA and S1479D
signiﬁcantly shifted the half inactivation potential to more depo-
larized potentials; and both PMA and the S1479D signiﬁcantly
increased the time constants for current inactivation. The effects
of PMA on these transient current properties were prevented by
PKC antagonists Bis I or chelerythrine (Table 1 and Supplemental
Fig. 2). The phosphorylation-deﬁcient mutant S1479A did not
cause any changes in regular current properties (Table 1 and
Supplemental Fig. 2). On the other hand, slope factors for current
gating voltage-dependence were only modulated by S1479E
compared to PMA (Table 1 and Supplemental Fig. 2). The results
suggested that PKC modulated transient current properties
through phosphorylation of S1479 in hNav1.7 channels.
4. Discussion
Researchers have shown that sodium resurgent currents can be
modulated by a variety of factors such as sodium channel mutation
[12,14], sodium channel b4 subunit [1], natural toxins [13] and
chemotherapy drugs [18]. Resurgent currents can be up-regulated
by inﬂammatory mediators associated with pain hypersensitivity
[20] or in epilepsy models [9]. However to our knowledge, there
is only one published study investigating the possible roles of cell
signaling in modulating resurgent currents [7]. In this study, the
authors found that intracellular application of alkaline phospha-
tase abolished resurgent currents in cerebellar Purkinje neurons.
The results indicated that constitutive phosphorylation of some
part of the sodium channel complex is necessary for producing
resurgent currents in Purkinje neurons. In the current report, we
showed that PKC activation by PMA increased resurgent currents
of hNav1.7 in HEK193 cells. These effects were blocked by PKC
antagonists Bis I and chelerythrine. Our results show for the ﬁrst
time that a speciﬁc protein kinase, PKC, can modulate sodium
resurgent currents.
We recently showed that a group of inﬂammatory mediators
including PGE2, Bradykinin, ATP, histamine, and serotonin can
Fig. 2. Increase of hNav1.7 resurgent currents by phosphorylation-mimicking mutations. Representative resurgent currents were recorded from HEK 293 cells expressing WT
and mutant hNav1.7 channels in the presence of 200 lM b4 peptide in the patch pipettes. The currents were recorded using the voltage protocol shown in Fig. 1F. Note that
currents are scaled to reﬂect the ratio resurgent currents. The ratio resurgent currents were calculated by normalizing peak resurgent currents to peak transient currents
recorded in the same cells. One phosphorylation-mimicking mutant S1479D dramatically increased resurgent currents compared to control. The other phosphorylation-
mimicking mutant S1479E showed a trend increase in resurgent current compared to WT (P < 0.10). (D and E) a phosphorylation-deﬁcient mutant (S1479A) did not change
resurgent currents by itself. However, S1479A prevented the increasing effects of PMA on resurgent currents shown in Fig. 1. (F) Summary of ratio resurgent current. The data
were presented as Means ± Standard Errors. ⁄⁄P < 0.01 (One way ANOVA, Tukey test).
Fig. 3. Increase of PEPD mutant resurgent currents by PMA. Representative
resurgent currents were recorded from HEK 293 cells expressing a PEPD mutant
of hNav1.7 (M1627 K) in the presence of 200 lM b4 peptide in the patch pipettes.
The currents were recorded using the voltage protocol shown in Fig. 1F. Note that
currents are scaled to reﬂect the ratio resurgent currents. The ratio resurgent
currents were calculated by normalizing peak resurgent currents to peak transient
currents recorded in the same cells. (A and B) PMA increased resurgent currents
compared to control M1627 K. (C) Summary of ratio resurgent current. The data
were presented as Means ± Standard Errors. ⁄P < 0.05 (Student t test).
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inﬂammatory mediators can activate the PKC pathway, either
directly or indirectly [17,27]. The current ﬁnding of PKC increasing
resurgent currents of hNav1.7 in HEK293 cells suggest that PKC
activation might contribute to the effects of inﬂammatory media-
tors on resurgent currents in DRG neurons. However, because the
cell environment and sodium channels isoforms can affect genera-
tion of resurgent currents in endogenous neurons [16,6], further
studies need to be conducted to fully test this possibility. It would
be interesting to test if other protein kinases contribute to the
enhancing effects of inﬂammatory mediators on resurgent currents
in DRG neurons. For example, ERK1/2 activation was found to
directly phosphorylate Nav1.7 and an ERK1/2 inhibitor caused a
depolarizing shift in the activation curve of Nav1.7 and decreased
excitability of DRG neurons [19].
Three conserved PKC phosphorylation sites in sodium channels
have been reported [28,3]. Two of them are located in the domain
I–II loop; the other one is located in the domain III–IV loop close
to IFM inactivation gate. In the current study, we found that two
phosphorylation-mimicking mutations at the conserved phos-
phorylation site in the domain III–IV loop, which is S1479 in
hNav1.7, increased or showed a trend increase of resurgent cur-
rents. Furthermore, a phosphorylation-deﬁcient mutant at the
same site (S1479A) prevented the increasing effects of PMA on
resurgent currents. The results suggest PKC activation can
increase resurgent current of hNav1.7 through a conserved phos-
phorylation site in the domain III–IV loop. The current study did
not mutate the other two phosphorylation sites or test the effects
of PKC activation on resurgent currents in the S1479D and
S1479E mutants. Therefore, a contributing role of other phosphor-
ylation sites to the enhancing effects of PKC activation cannot be
fully excluded.
Table 1
Effects of PKC activation on current properties of regular hNav1.7 currents.
Gating Properties Kinetics
Activation Inactivation Activation Inactivation
V0.5 (mV) sf (mV) V0.5 (mV) sf (mV) sm (ms) sh (ms)
Control 27.5 ± 2.3 6.0 ± 0.3 78.3 ± 2.1 7.4 ± 0.2 0.33 ± 0.01 1.30 ± 0.16
n 14 14 13
PMA 19.3 ± 2.4⁄ 6.1 ± 0.2 71.6 ± 1.5⁄ 7.6 ± 0.5 0.42 ± 0.01⁄⁄ 2.16 ± 0.25⁄
n 18 18 16
BisI + PMA 21.6 ± 1.2 6.8 ± 0.3 75.9 ± 1.3 7.6 ± 0.2 0.38 ± 0.03 1.74 ± 0.13
n 8 8 7
Che + PMA 23.9 ± 2.0 6.1 ± 0.4 76.1 ± 1.4 7.3 ± 0.3 0.38 ± 0.03 1.56 ± 0.20
n 6 6 5
WT 27.9 ± 1.2 6.1 ± 0.2 80.2 ± 1.1 7.3 ± 0.2 0.31 ± 0.02 1.47 ± 0.11
n 19 19 16
S1479D 23.9 ± 1.2 6.2 ± 0.3 71.8 ± 1.6⁄⁄ 8.3 ± 0.5 0.37 ± 0.01 3.24 ± 0.27⁄⁄
n 11 11 11
S1479E 21.4 ± 2.0⁄ 7.5 ± 0.4⁄ 79.9 ± 2.3 8.9 ± 0.6⁄ 0.32 ± 0.04 1.85 ± 0.15
n 9 9 6
S1479A 24.7 ± 2.3 6.3 ± 0.5 79.8 ± 1.9 7.3 ± 0.3 0.27 ± 0.03 1.18 ± 0.23
n 8 8 5
Values are mean ± S.E.; n is number of cells. V0.5, half activation/inactivation potential; sf, slope factor; sm, activation time constant at 20 mV; sh, inactivation time constant
at 20 mV. ⁄P < 0.05, ⁄⁄P < 0.01 (One way ANOVA, Tukey test, signiﬁcant difference between indicated group and Control or WT).
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channels expressed in different tissues. PKC activation reportedly
slowed time-dependent inactivation in the brain sodium channel
Nav1.2 through the conserved phosphorylation site in the domain
III–IV loop [28]. PKC caused a hyperpolarizing shift of steady-state
inactivation in cardiac (Nav1.5) and skeletal (Nav1.4) sodium chan-
nel with different mechanisms [2,15]: the effects on Nav1.5, but
not for Nav1.4, are dependent on the conserved phosphorylation
site in domain III–IV loops. PKC activation resulted in a depolariz-
ing shift of steady-state activation in peripheral sodium channel
isoforms Nav1.7 and Nav1.8 in Xenopus oocytes [25]. In the current
study using HEK293 cells, we found that PKC activation by PMA
signiﬁcantly shifted gating curves of both steady-state activation
and inactivation to more depolarized potentials, and slowed
time-dependent current activation and inactivation. We further
found that phosphorylation-mimicking mutants of S1479 showed
similar effects on gating and kinetic properties of hNav1.7. The
results reproduce some of the previous ﬁndings of slowing inacti-
vation in Nav1.2 [28] and shifting the steady-state activation of
Nav1.7 to more depolarized potentials [25]. Toxins that slow inac-
tivation [13] and some disease mutations that slow inactivation
[12] can enhance resurgent sodium currents in neurons. Although
PKC phosphorylation of S1479 does not seem to be absolutely nec-
essary for the generation of resurgent currents, PKC slowing of
inactivation can increase resurgent current amplitudes and, as
with toxin and disease mutation induced resurgent currents, this
is likely to contribute to increased neuronal excitability.
PKC was reported to have diverse effects on Nav1.7 in terms of
transient current density or protein expression in different tissue.
In in vitro cultured DRG neurons, PKC was found to increase
Nav1.7 expression [4]. One the other hand, PKC decreased Nav1.7
current or expression in Xenopus oocytes [25] or adrenal chromaf-
ﬁn cells [26]. In the current study using HEK 293 cells, we did not
see a signiﬁcant change in transient current density caused by PKC
activation. These results suggest PKC can have complex effects on
Nav1.7 current or channel expression in different tissues and
conditions.
In summary, while phosphorylation of S1479 is not necessary
for Nav1.7 resurgent current generation, it can substantially
increase Nav1.7 resurgent current amplitude. As this site is con-
served in Nav1.1–Nav1.8, we predict that PKC is likely to modulate
resurgent currents in multiple isoforms through phosphorylation
of this conserved Serine.Acknowledgements
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